Cellbion

308430

Company Profile

  • Business description

    Cellbion is a radiopharmaceutical innovation engaged in the development and commercialization of radioligand therapies to address unmet medical needs, focusing on improving patient outcomes and advancing healthcare through groundbreaking research and cutting-edge technology. Its pipeline products targeted indications are Prostate Cancer radiotherapy, Solid Tumors Diagnosis, Multiple Cancer types, and Others.

  • Contact

    103, Daehak-ro
    6th Floor
    Jongno-gu
    Seoul03080
    KOR

    T: +82 27433311

    http://www.cellbion.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,374.0082.20-0.97%
CAC 407,735.8534.63-0.45%
DAX 4023,349.25262.601.14%
Dow JONES (US)41,365.1147.680.12%
FTSE 1008,596.3599.551.17%
HKSE22,504.68385.271.74%
NASDAQ17,883.1394.60-0.53%
Nikkei 22536,830.69378.391.04%
NZX 50 Index12,421.2593.360.76%
S&P 5005,666.5620.11-0.35%
S&P/ASX 2008,157.8080.20-0.97%
SSE Composite Index3,279.037.62-0.23%

Market Movers